Neointima formation in a restenosis model is suppressed in midkine-deficient mice
about
Serum midkine levels are increased in patients with various types of carcinomasCorrelation of elevated level of blood midkine with poor prognostic factors of human neuroblastomasMidkine and the kidney: health and diseasesMidkine in nephrogenesis, hypertension and kidney diseasesMidkine in host defenceStructure and function of midkine as the basis of its pharmacological effectsMidkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell typesInhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancerHaptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinaseRNA plasticity and selectivity applicable to therapeutics and novel biosensor developmentMAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation.Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction.Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compoundsA comparative anatomic and physiologic overview of the porcine heart.Nuclear targeting by the growth factor midkine.Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomasMidkine as a factor to counteract the deposition of amyloid β-peptide plaques: in vitro analysis and examination in knockout mice.Neuroglycan C is a novel midkine receptor involved in process elongation of oligodendroglial precursor-like cells.Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1Midkine-deficiency delays chondrogenesis during the early phase of fracture healing in miceGrowth factor midkine is involved in the pathogenesis of diabetic nephropathy.A single intracoronary injection of midkine reduces ischemia/reperfusion injury in Swine hearts: a novel therapeutic approach for acute coronary syndrome.Midkine, a potential link between obesity and insulin resistanceMidkine: a promising molecule for drug development to treat diseases of the central nervous systemMidkine Regulates BP through Cytochrome P450-Derived Eicosanoids.Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.The advances of Midkine with peripheral invasion in pancreatic cancer.Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population.Midkine as a prognostic biomarker in oral squamous cell carcinoma.Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease.Gene therapy to prevent occlusion of venous bypass grafts.The growth factor midkine regulates the renin-angiotensin system in miceMidkine: a novel prognostic biomarker for cancer.Therapeutic potential of midkine in cardiovascular disease.PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells.Midkine in the pathology of cancer, neural disease, and inflammation.Lessons from the heart and ischemic limbs: midkine as anti-inflammatory mediator for kidney diseases?The heparin-binding growth factor midkine: the biological activities and candidate receptors.Midkine in repair of the injured nervous systemMidkine and multiple sclerosis.
P2860
Q24649020-B06467B0-F7DE-4D12-897A-0620BC9E1B40Q24656678-706F367B-D88F-4BCB-94DF-3BA5020079FAQ27005733-BFF57F23-2AF8-4235-BB90-70E678621CFEQ27006801-E9E4E8BB-8453-427F-809B-3CC3726F18DAQ27010045-34E64B0B-6F6F-422C-BA87-8ED3C133E663Q27013798-FD1A53DC-71DE-40EC-B9E1-8DF0C8273B3CQ28214927-98385CC0-78D8-4901-BFAF-60C2976936B7Q28535406-F9124219-D9AE-41F5-BC5E-93058AEF1061Q28565517-49C3BE12-F1BF-44D7-A784-C25367156B92Q28727743-56250968-4493-4927-B731-BF17125FAA2CQ30418359-63169199-58B7-42E9-8D2D-32F5B5C8CB81Q33746629-F3F5E192-924B-4061-9AAF-721764B6A9DEQ33968267-A42CE400-C70B-48BD-A9DD-9265228E9FF9Q34274290-65FC682C-0D98-4DEC-9B7C-5FEAC5DF30ECQ34286252-50D6EE0F-40B6-4DEC-9E90-5939239FE0FCQ34399073-237B33B0-34AE-4C15-A74E-D6AB7E23C6E0Q34506576-AE1EE498-68EA-4477-AE92-94869B2B1090Q34556247-66ABE4E3-1104-4F59-B25F-6194E1124815Q34624412-307631A0-67FD-4C79-BAFE-72A984D66015Q34796845-FB4C7E09-00E1-4283-B8B3-FF9E828BC4DCQ35070717-757FEE02-BDBB-4781-A24B-A8D25F78B46AQ35075119-DB0541ED-3179-4FDC-8405-60441825232AQ35091683-CF467450-F95D-4152-BB6B-7DF8D49004FFQ35701268-5D8DE554-4591-48B3-8F1B-B69285472844Q35903066-44AB03E8-9780-40AD-AE8A-C3B12F429BD4Q36160231-B6BCA94B-B106-493A-BF69-2F3677543C28Q36250696-10019498-18D9-49C2-AACD-1A53EB4F1CFAQ36499318-B5DA3BF2-D5B1-44DE-ACE1-BEFCF07BD0C5Q36858230-155E117B-16D4-4D21-A5B4-C475EB6B880FQ37092811-858DA655-CBE0-4B87-8434-2E56983C6247Q37176430-A5291F58-0288-4D60-9EEB-629471EC1930Q37209205-211283A5-72F1-41EC-AB6E-C915FEF69224Q37328317-3B7A2252-AD3D-4C13-979F-34B9F32789AEQ37585406-33A18DF9-25EF-4DCD-B08D-50E7BFFB10DEQ37655955-DBBA534E-5315-4CC7-8905-72A7AA0C9CC1Q38020971-5B1E9CB5-D55C-4B70-9131-636D2C77B6CBQ38064786-32793706-918E-452D-941E-F5CC9DBCFD05Q38102670-2C29E416-0273-417B-93E7-EE55CC1907C1Q38181592-AB6C4D31-9FB4-4CAB-80B6-6EDB1EE7AEBDQ38181593-AE1AF5E5-9529-43C1-A2CC-86F3C572CB07
P2860
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
description
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Februar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/02/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/02/01)
@nl
наукова стаття, опублікована в лютому 2000
@uk
مقالة علمية (نشرت في فبراير 2000)
@ar
name
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@ast
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@en
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@nl
type
label
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@ast
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@en
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@nl
prefLabel
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@ast
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@en
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@nl
P2093
P2860
P921
P3181
P356
P1476
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
@en
P2093
E. Nakamura
H. Muramatsu
K. Hayashi
K. Kadomatsu
S. Ikematsu
P2860
P304
P3181
P356
10.1172/JCI7208
P407
P577
2000-02-01T00:00:00Z